Nasal Spray Technology Platform
- The unique formulas enable the liquid medication to remain longer in the nasal cavity and extended the time of drug release.
- The formulations enable quick local absorption for better treatment results and reduced systemic side effects.
- Synmosa's product developments follow strict guidelines. The analytical results meet the US FDA's guidance of bioequivalence for nasal spray. The analytical items include:
- A. Single Dose Content Uniformity Through Container Life
- B. Droplet/Particle Size Distribution
- C. Spray Pattern
- D. Plume Geometry
- E. Priming and Re-priming
- F. Analyze Drug Distribution by Cascade Impactor
The Leading brand in Nasal Spray products.